EMA And FDA Co-Operate To Reduce GMP Inspections Burden
This article was originally published in The Pink Sheet Daily
Executive Summary
EMA and FDA are offering to conduct joint GMP inspections for certain manufacturing sites, but pharma has been slow to respond.